Skip to main content
Journal of Crohn's & Colitis logoLink to Journal of Crohn's & Colitis
. 2022 Dec 29;17(3):462. doi: 10.1093/ecco-jcc/jjac180

Erratum to: Tofacitinib for the Treatment of Ulcerative Colitis: An Integrated Summary of up to 7.8 Years of Safety Data from the Global Clinical Programme

PMCID: PMC10069613  PMID: 36579949

This is an erratum to: William J Sandborn, Geert R D’Haens, Bruce E Sands, Remo Panaccione, Siew C Ng, Nervin Lawendy, Nicole Kulisek, Irene Modesto, Xiang Guo, Rajiv Mundayat, Chinyu Su, Ivana Vranic, Julian Panés, Tofacitinib for the Treatment of Ulcerative Colitis: An Integrated Summary of up to 7.8 Years of Safety Data from the Global Clinical Programme, Journal of Crohn’s and Colitis, 2022, jjac141, https://doi.org/10.1093/ecco-jcc/jjac141

In the originally published version of this manuscript, a link for the plain language summary was not included.

An infographic plain language summary of this paper is available at: [https://pfizer.figshare.com/articles/journal_contribution/Plain_language_summary_for_the_manuscript_Tofacitinib_for_the_Treatment_of_Ulcerative_Colitis_An_Integrated_Summary_of_up_to_7_8_Years_of_Safety_Data_from_the_Global_Clinical_Programme/21652322]

This error has been corrected.


Articles from Journal of Crohn's & Colitis are provided here courtesy of Oxford University Press

RESOURCES